Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Achilles Therapeutics
(ACHL) Q4 2022
Earnings
ACHL
Mar 7
Confirmed
May 2022
Aug 2022
Nov 2022
Q4 2022
-0.61
-0.51
-0.42
-0.32
Details
Expected EPS
-0.41
Actual EPS
-0.61
Surprise EPS
-0.2
Surprise Percent
-48.78%
Description
Achilles Therapeutics (ACHL) has reported earnings of -0.61 per share for Q4 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login